Paradigm Biopharmaceuticals Ltd.ASX: PAR

Hay Fever Trial Update

Jun 16, 2017 at 3:21 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment